<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to the adult with recurrent infections</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to the adult with recurrent infections</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Approach to the adult with recurrent infections</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark S Pasternack, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jordan S Orange, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna M Feldweg, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 18, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Adult patients who present with recurrent infections pose a dilemma to the generalist. In most cases, there is a secondary cause, such as an anatomic abnormality or established systemic illness. However, secondary immune defects due to other medical disorders are sometimes identified, while primary immune defects (also called inborn errors of immunity) presenting in adults are rare. The initial approach to an adult patient with recurrent infections is discussed here, with a discussion of the nonimmunologic disorders that should be considered in the evaluation of recurrent infection at specific anatomic sites and a brief overview of immunodeficiency in adults. The laboratory tests that are used to evaluate the various components of the immune system are reviewed separately. (See  <a class="medical medical_review" href="/d/html/3903.html" rel="external">"Laboratory evaluation of the immune system"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">OVERVIEW OF ETIOLOGIES</span><span class="headingEndMark"> — </span>In adults, recurrent infections are usually due to an anatomic lesion, a functional disorder, or to a secondary cause of immunosuppression.</p><p>It is helpful to consider the following broad categories of etiologies when evaluating an adult with recurrent infections:</p><p class="bulletIndent1"><span class="glyph">●</span>Anatomic lesions, whether congenital or acquired, and disorders affecting the function of specific organs are important causes of recurrent infections in adults (<a class="graphic graphic_table graphicRef87023" href="/d/graphic/87023.html" rel="external">table 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Secondary immune disorders due to other medical conditions or treatments for these conditions are a much more common cause of recurrent infections than primary immunodeficiencies (<a class="graphic graphic_table graphicRef71244" href="/d/graphic/71244.html" rel="external">table 2</a>). (See <a class="local">'Secondary immunodeficiency'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most congenital (primary) immunodeficiencies do not present in adulthood but rather are diagnosed in infancy or childhood, because patients with these disorders often require repeated hospitalizations for serious infections at an early age and may develop growth retardation from chronic and recurrent illnesses [<a href="#rid1">1-4</a>]. An important exception is common variable immunodeficiency (CVID), which is relatively common, can present in both children or adults, and is characterized by low IgG combined with low IgM or low IgA. However, the number of recognized immunodeficiencies (presently &gt;400) has expanded dramatically in recent decades as a result of increasing genomic analysis, and primary immunodeficiency is probably not as rare as previously thought. In addition, there are increasing reports of milder phenotypes of disorders that were previously recognized only in their most severe forms (eg, DiGeorge syndrome). (See <a class="local">'Primary immunodeficiency'</a> below.)</p><p></p><p class="headingAnchor" id="H7"><span class="h1">CLINICAL EVALUATION</span><span class="headingEndMark"> — </span>The evaluation of an adult with recurrent infections begins with a complete history and thorough physical examination.</p><p class="headingAnchor" id="H8541745"><span class="h2">History and documentation of infections</span><span class="headingEndMark"> — </span>The clinical history should include a careful review of the patients' past medical problems and their treatments, surgeries, accidental injuries, and medications. Microbiologic data, including culture and susceptibility testing, and imaging studies documenting the presence of infections should be retrieved or obtained for past and current infections, whenever possible. The etiology and subsequent approach varies according to the type and pattern of infections present.</p><p class="headingAnchor" id="H4545049"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>The physical examination of a patient with a history of recurrent infections may reveal anatomic abnormalities or signs and stigmata of significant underlying disorders (eg, venous insufficiency). Patients with longstanding immune defects may display low body mass index (BMI), sequelae of recurrent infection in the form of scarring (of tympanic membranes or skin), signs of chronic lung disease (chronic cough, absent gag reflex, clubbing, crackles, or wheezing to suggest bronchiectasis), or ongoing infection (signs of chronic sinusitis, oral thrush, warts, or dermatophyte infections). Lymphadenopathy and/or hepatosplenomegaly can be seen with antibody deficiencies, as can arthritic changes.</p><p class="headingAnchor" id="H8541765"><span class="h2">Family history</span><span class="headingEndMark"> — </span>A detailed family history is important for the detection of primary immunodeficiencies. Severe and/or recurrent febrile illnesses or infections or childhood deaths in relatives may suggest an X-linked or autosomal recessive immune disorder. Consanguinity increases the likelihood that a rare autosomal recessive condition could be expressed. Multiple family members with autoimmune diseases or malignancies should also raise the suspicion of a familial immune disorder.</p><p class="headingAnchor" id="H15"><span class="h1">CONSIDERATIONS BY SITE OF INFECTION</span><span class="headingEndMark"> — </span>Patients will sometimes present with recurrent infections of one type. In this setting, there are specific nonimmunologic conditions which should be considered before an immune evaluation is undertaken.</p><p class="headingAnchor" id="H16"><span class="h2">Skin infections</span><span class="headingEndMark"> — </span>Skin infections, in isolation, are not usually indicative of an underlying primary immunodeficiency.</p><p class="headingAnchor" id="H2112541945"><span class="h3">Impetigo</span><span class="headingEndMark"> — </span>Eczema (atopic dermatitis) is often complicated by recurrent staphylococcal and/or streptococcal impetigo, presumably due to the disruption of the intact epidermal layer. Cutaneous viral infections due to herpes simplex, vaccinia, and coxsackie virus are also associated with underlying eczema [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/d/html/7655.html" rel="external">"Impetigo"</a>.)</p><p class="headingAnchor" id="H17"><span class="h3">Cellulitis</span><span class="headingEndMark"> — </span>Cellulitis is likely to recur in the setting of venous or lymphatic stasis (lymphedema) and/or breaches in the skin barrier (eg, dermatophyte infections or trauma). (See  <a class="medical medical_review" href="/d/html/110529.html" rel="external">"Cellulitis and skin abscess: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphedema can be classified as primary (congenital) or secondary (acquired) disease. Lymphedema in adults is most often due to axillary or inguinal lymph node dissection and/or radiation, and such patients have an increased risk of cellulitis. Patients from endemic areas may present with lymphedema as a sequela of filariasis. (See  <a class="medical medical_review" href="/d/html/755.html" rel="external">"Clinical features and diagnosis of peripheral lymphedema"</a> and  <a class="medical medical_review" href="/d/html/7645.html" rel="external">"Cellulitis following pelvic lymph node dissection"</a> and  <a class="medical medical_review" href="/d/html/797.html" rel="external">"Breast cellulitis and other skin disorders of the breast"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A previous episode of cellulitis itself can lead to lymphatic scarring and impaired lymphatic drainage, thereby promoting the development of recurrent cellulitis. This has been best described after saphenous venectomy for coronary artery bypass graft surgery. (See  <a class="medical medical_review" href="/d/html/1585.html" rel="external">"Early noncardiac complications of coronary artery bypass graft surgery", section on 'Post-venectomy cellulitis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dermatophyte infections can predispose patients to recurrent cellulitis, especially when tinea pedis develops after saphenous venectomy. The dermatophyte infection provides a portal of entry for bacteria, most often streptococci or staphylococci, and predisposes to the development of cellulitis. The frequency of infections in these patients is often reduced by treatment of dermatophyte infections and other primary dermatologic conditions, meticulous podiatric care, and consideration of antibiotic prophylaxis. (See  <a class="medical medical_review" href="/d/html/1585.html" rel="external">"Early noncardiac complications of coronary artery bypass graft surgery", section on 'Post-venectomy cellulitis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic edema also increases the risk of recurrent cellulitis. Venous insufficiency, congestive heart failure, hepatic disease, nephrotic syndrome, and malnutrition are all causes of chronic edema that predispose patients to recurrent cellulitis. These underlying diagnoses should be considered during the evaluation of recurrent cellulitis in patients with unexplained edema. (See  <a class="medical medical_review" href="/d/html/2309.html" rel="external">"Pathophysiology and etiology of edema in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peripheral arterial disease with ischemia is associated with an increased risk of recurrent skin infection in the affected limbs. The presence of ischemic ulcers provides a ready portal of entry for progressive local infection, exacerbated by poor arterial inflow and delivery of granulocytes and antibiotics. (See  <a class="medical medical_review" href="/d/html/8208.html" rel="external">"Clinical features and diagnosis of lower extremity peripheral artery disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obesity has also been reported as a risk factor for recurrent cellulitis. It is possible that lower extremity venous stasis and/or lymphatic stasis due to hydrostatic issues in these individuals is responsible for their increased risk of infection [<a href="#rid6">6,7</a>]. (See  <a class="medical medical_review" href="/d/html/5861.html" rel="external">"Clinical evaluation of the child or adolescent with obesity"</a>.)</p><p></p><p class="headingAnchor" id="H18"><span class="h3">Abscess</span><span class="headingEndMark"> — </span>Recurrent abscess formation in the same anatomic location often arises from a local defect, such as a congenital branchial cleft cyst, pilonidal or urachal cyst, hidradenitis suppurativa, or a retained foreign body. In these situations, recurrent infection is limited to the neck, axilla, groin, umbilicus, or site of previous trauma, and there is no need to suspect a generalized susceptibility to infection [<a href="#rid8">8</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Occasionally, Crohn disease can lead to inguinal and/or perianal abscesses, complicating enteric fistula, and intra-abdominal abscess formation. Immunodeficiencies that can present in adults with inflammatory bowel disease include chronic granulomatous disease, antibody deficiencies, and deficiency of the X-linked inhibitor of apoptosis (XIAP). (See  <a class="medical medical_review" href="/d/html/4070.html" rel="external">"Clinical manifestations, diagnosis, and prognosis of Crohn disease in adults"</a> and  <a class="medical medical_review" href="/d/html/99315.html" rel="external">"Gastrointestinal manifestations in primary immunodeficiency", section on 'Inflammatory bowel disease'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with risk factors for acquired immunosuppressive conditions predisposing to infection (such as diabetes, human immunodeficiency virus [HIV] infection, and other disorders noted in the table (<a class="graphic graphic_table graphicRef71244" href="/d/graphic/71244.html" rel="external">table 2</a>)) should undergo screening for these conditions. (See  <a class="medical medical_review" href="/d/html/1761.html" rel="external">"Screening for type 2 diabetes mellitus"</a> and  <a class="medical medical_review" href="/d/html/3736.html" rel="external">"Screening and diagnostic testing for HIV infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multiple or recurrent abscesses in a variety of locations may be the result of autoinoculation in the setting of drug abuse (subcutaneous drug injection or "skin-popping") or Munchausen syndrome [<a href="#rid9">9,10</a>]. (See  <a class="medical medical_review" href="/d/html/7765.html" rel="external">"Factitious disorder imposed on self (Munchausen syndrome)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The epidemic of community-acquired methicillin-resistant <em>Staphylococcus aureus</em> (CA-MRSA) infection involving strains related to clone USA300 has led to a striking increase in the number of individuals with recurrent superficial skin abscesses. These patients are otherwise well, and immunologic evaluation can generally be restricted to those with recurrent deep infections (pyomyositis, skeletal infection, necrotizing pneumonia, etc). Preventive measures for reducing the spread of staphylococci may be helpful for reducing the risk for recurrent skin infection and are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/4048.html" rel="external">"Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Prevention and control"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Granulocyte disorders can present with recurrent abscesses. These may be acquired and quantitative (eg, myelofibrosis and other causes of progressive marrow failure) or inborn and qualitative (eg, chronic granulomatous disease). (See  <a class="medical medical_review" href="/d/html/3925.html" rel="external">"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis", section on 'Gastrointestinal'</a>.)</p><p></p><p class="headingAnchor" id="H1511872587"><span class="h3">Mucocutaneous candidiasis</span><span class="headingEndMark"> — </span>Common candidal infections include oropharyngeal candidiasis (thrush), esophagitis, vulvovaginitis, balanitis, and mastitis in lactating women. Typical presentations and predisposing factors are reviewed elsewhere. (See  <a class="medical medical_review" href="/d/html/2416.html" rel="external">"Overview of Candida infections"</a>.)</p><p>In contrast, chronic mucocutaneous candidiasis (CMCC) is a rare syndrome affecting the skin, oral and genital mucosal surfaces, lips, and nails with persistent infection and striking dystrophic changes (<a class="graphic graphic_picture graphicRef64895" href="/d/graphic/64895.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef71698" href="/d/graphic/71698.html" rel="external">picture 2</a>). It usually begins in childhood and is seen in association with several underlying immunologic disorders. Candidal infections rarely progress to invasive systemic infections in CMCC, which distinguishes this disorder from the systemic infections seen with more profound T cell immunodeficiencies. Referral for immunologic evaluation is appropriate. (See  <a class="medical medical_review" href="/d/html/13569.html" rel="external">"Chronic mucocutaneous candidiasis"</a>.)</p><p class="headingAnchor" id="H198241626"><span class="h3">Recurrent herpes simplex</span><span class="headingEndMark"> — </span>Patients with frequent and/or severe oral, cutaneous, or genital herpes infections are often referred for formal infectious diseases consultation.</p><p class="bulletIndent1"><span class="glyph">●</span>The hallmark of herpes group virus infections is persistent (latent) neuronal viral infection, with the risk of recurrent regional disease throughout life. The frequency of recurrence varies widely among different individuals (from one or two episodes over a lifetime to approximately one episode monthly) and is likely determined by multiple factors, including age at the time of primary infection, age at the time of recurrence (immunologic immaturity in infancy, waning immune protection in advanced age), viral strain variations, inflammatory triggers in the distribution of the latently-infected neurons, and underlying host diseases. (See  <a class="medical medical_review" href="/d/html/8334.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Recurrent infection'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with occasional recurrences respond well to episodic treatment with antiviral therapies, self-administered at the first sign of recurrence. Patients with very frequent recurrences, a problem seen during the first few years after primary infection in some individuals, may be offered maintenance suppression therapy. (See  <a class="medical medical_review" href="/d/html/8287.html" rel="external">"Treatment and prevention of herpes simplex virus type 1 in immunocompetent adolescents and adults", section on 'Prophylaxis for recurrent HSV with identified trigger'</a> and  <a class="medical medical_review" href="/d/html/8346.html" rel="external">"Treatment of genital herpes simplex virus infection", section on 'Treatment of recurrent infection'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immunocompetent individuals usually experience satisfactory control with episodic or maintenance suppression. In contrast, immunodeficient patients may develop refractory or progressive primary infection or very frequent relapses despite appropriate antiviral therapy. These individuals should be evaluated for underlying T or natural killer (NK) cell dysfunction, although in many instances, the underlying immunologic disorders are known at the time of presentation with severe herpes simplex. (See <a class="local">'Initial immunologic evaluation'</a> below.)</p><p></p><p>In patients with recurrent or severe outbreaks, it is important to confirm the diagnosis of herpes simplex, preferably by direct immunofluorescence, viral culture, molecular diagnosis utilizing PCR, or serology, depending upon available laboratory resources. Two disorders that may mimic recurrent herpes simplex are nonherpetic aphthous ulcers, which often respond to topical corticosteroids, and recurrent herpes zoster, which may become less frequent following administration of the zoster vaccine. (See  <a class="medical medical_review" href="/d/html/8334.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/d/html/112654.html" rel="external">"Recurrent aphthous stomatitis"</a> and  <a class="medical medical_review" href="/d/html/8327.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes zoster"</a>.)</p><p class="headingAnchor" id="H973496964"><span class="h3">Recurrent herpes zoster</span><span class="headingEndMark"> — </span>More than one episode of herpes zoster is uncommon but not rare in an immunocompetent individual, and usually recurs in distinct dermatomal distributions. In a population-based study, Mayo Clinic investigators demonstrated a recurrence rate of 5.7 percent over an eight-year follow-up of immunocompetent patients [<a href="#rid11">11</a>]. In contrast, zoster can be recurrent in patients with HIV infection. Herpes simplex occurring outside of the mouth, lips, and genitals can also be mistaken for herpes zoster, so it is desirable to confirm the type of infection. Recurrent zoster is reviewed separately. (See  <a class="medical medical_review" href="/d/html/8327.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes zoster"</a> and  <a class="medical medical_review" href="/d/html/8327.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes zoster", section on 'Recurrent herpes zoster'</a>.)</p><p class="headingAnchor" id="H1217342898"><span class="h3">Initial immunologic evaluation</span><span class="headingEndMark"> — </span>Immunologic evaluation would be appropriate in patients with recurrent cellulitis or abscesses affecting <strong>different</strong> sites who do not have predisposing lymphatic or venous abnormalities or associated dermatologic conditions.</p><p class="bulletIndent1"><span class="glyph">●</span>Neutropenia should be excluded as a risk factor by routine differential white blood cell count. (See  <a class="medical medical_review" href="/d/html/90654.html" rel="external">"Approach to the adult with unexplained neutropenia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A variety of functional defects in phagocytes should also be considered. These disorders are rare in general and present with combinations of skin and respiratory tract infections. Tissue and organ focal infections (phlegmon, granuloma, abscess, or pneumonitis with or without necrotizing features) also occur. Other frequent manifestations include abnormal wound healing, dermatitis/eczema, stomatitis, and inflammatory bowel disease. Referral to an allergist/immunologist or infectious diseases specialist would be prudent to help guide further testing. (See <a class="local">'Referral'</a> below and  <a class="medical medical_review" href="/d/html/3913.html" rel="external">"Primary disorders of phagocyte number and/or function: An overview"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with recurrent herpes simplex despite appropriate suppressive therapies or in patients with recurrent herpes zoster, testing for HIV as well as T and NK cell quantitation are indicated. Occasionally, NK cell functional assessment is performed, although this should be done in consultation with an immunology specialist. (See  <a class="medical medical_review" href="/d/html/3903.html" rel="external">"Laboratory evaluation of the immune system", section on 'Flow cytometry for cell populations'</a> and  <a class="medical medical_review" href="/d/html/3949.html" rel="external">"NK cell deficiency syndromes: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H20"><span class="h2">Respiratory tract infections</span><span class="headingEndMark"> — </span>Recurrent respiratory infections are extremely common, and most patients do not have an underlying immune defect or suffer from other more serious infections. However, recurrent respiratory tract infections in combination with more serious infections are a classic presentation of antibody deficiencies.</p><p class="headingAnchor" id="H21"><span class="h3">Sinusitis</span><span class="headingEndMark"> — </span>Recurrent sinusitis in isolation is rarely associated with an immunodeficiency state and more likely reflects underlying allergic rhinitis, inadequate antibiotic therapy, or a local anatomic defect (eg, nasal polyposis or structural abnormalities due to a deviated nasal septum, narrowed sinus ostia, or past facial trauma), particularly when there is recurrent unilateral disease. However, recurrent sinusitis in isolation is occasionally seen in the less severe antibody deficiencies, including specific antibody deficiency, immunoglobulin G (IgG) subclass deficiency, and selective immunoglobulin A (IgA) deficiency.</p><p>Inadequate antibiotic therapy is a common cause of apparent recurrent sinusitis and may arise from treatment that is either too brief or too narrow in its spectrum of antimicrobial activity. Patients may report multiple episodes of sinusitis over the course of several months. However, on careful questioning, the clinician can detect a pattern of improvement on antibiotics, with gradual return of symptoms within the first two weeks after completing therapy and then worsening to the point that another course of antibiotics was prescribed. This pattern suggests a single relapsing infection rather than multiple new infections.</p><p>In contrast, adult patients with recurrent or chronic sinus infections, in combination with lower respiratory tract infections or recurrent otitis media, may have a defect in antibody production or function, such as common variable immunodeficiency, IgG subclass deficiencies, or specific antibody deficiency with polysaccharide nonresponsiveness. A quantitative or qualitative granulocyte disorder or a deficiency of complement proteins are other possible explanations. (See  <a class="medical medical_review" href="/d/html/3928.html" rel="external">"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults"</a> and  <a class="medical medical_review" href="/d/html/3906.html" rel="external">"IgG subclass deficiency"</a> and  <a class="medical medical_review" href="/d/html/3965.html" rel="external">"Specific antibody deficiency"</a> and  <a class="medical medical_review" href="/d/html/3913.html" rel="external">"Primary disorders of phagocyte number and/or function: An overview"</a>.)</p><p class="headingAnchor" id="H22"><span class="h3">Pharyngitis</span><span class="headingEndMark"> — </span>Recurrent streptococcal pharyngitis usually reflects inadequacy of therapy to eradicate pharyngeal carriage of group A beta-hemolytic streptococci (GAS) rather than immunodeficiency. Molecular analyses of symptomatic patients show persistence of individual isolates rather than serial infection by independent strains. Once adequate medication adherence is ensured, symptomatic patients with recurrent pharyngitis often benefit from the use of a beta-lactamase-resistant agent. In some individuals, beta-lactamase production by oral flora is associated with penicillin failure [<a href="#rid12">12</a>].</p><p>Some patients are (noninvasive) carriers of pharyngeal group A streptococci and have positive throat cultures for group A streptococci when they are cultured in the setting of viral respiratory tract infections. (See  <a class="medical medical_review" href="/d/html/8049.html" rel="external">"Treatment and prevention of streptococcal pharyngitis in adults and children", section on 'Chronic GAS carriers'</a>.)</p><p class="headingAnchor" id="H23"><span class="h3">Pneumonia</span><span class="headingEndMark"> — </span>Patients with recurrent pneumonia often fall into one of two categories:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with recurrent pneumonia limited to a particular anatomic region (eg, right middle lobe), who generally have a local anatomic abnormality.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with sequential infections involving different regions of the lung, who are more likely to have an underlying systemic process rather than a local anatomic defect. Patients with recurrent pneumonia in association with other infections, such as sinusitis, otitis media, or bronchitis, are most likely to have an underlying immunodeficiency.</p><p></p><p>Patients with recurrent pneumonia limited to a particular anatomic region should be evaluated for an anatomic abnormality. This may be extrinsic to the trachea and bronchi (eg, bronchial compression by mediastinal adenopathy, neoplasm, or vascular anomaly) or intrinsic to the bronchus or alveoli (eg, retained foreign body, bronchiectasis, bronchomalacia, bronchial stenosis, tracheobronchial fistula, bronchial sequestration, or cyst) [<a href="#rid13">13,14</a>]. Patients with tracheal disorders, such as tracheobronchomegaly [<a href="#rid15">15</a>] or tracheomalacia, may have recurrent infections in a limited or more generalized pattern. (See  <a class="medical medical_review" href="/d/html/4406.html" rel="external">"Tracheomalacia in adults: Clinical features and diagnostic evaluation"</a> and  <a class="medical medical_review" href="/d/html/4387.html" rel="external">"Airway foreign bodies in adults"</a>.)</p><p>Other underlying conditions that predispose to recurrent pneumonia in a particular anatomic area include recurrent aspiration due to seizures, ethanol or other drug use, dysphagia, reflux, Zenker's diverticulum, or achalasia. These disorders can cause recurrent pneumonitis restricted to the lung bases and posterior segments. In such cases, a contrast swallow under fluoroscopy or other appropriate gastroenterologic studies should be considered.</p><p>In contrast, patients with sequential infections involving different regions of the lung are more likely to have an underlying systemic process rather than a local anatomic defect. Examples include:</p><p class="bulletIndent1"><span class="glyph">●</span>Prominent sinopulmonary disease may be seen in patients with cystic fibrosis and immotile cilia syndrome [<a href="#rid16">16-20</a>]. It is important to screen young adults with recurrent pneumonia and sinusitis for these processes, especially if symptoms suggestive of cystic fibrosis are present, as this may present in adulthood, and de novo mutations may be responsible for illness despite a negative family history. In adults with mild phenotypes and resultant late presentations, typical mucoid strains of Pseudomonas aeruginosa and/or S. aureus may be absent. (See  <a class="medical medical_review" href="/d/html/6367.html" rel="external">"Cystic fibrosis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/4338.html" rel="external">"Primary ciliary dyskinesia (immotile-cilia syndrome)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Noninfectious processes, particularly pulmonary vasculitis or bronchiolitis obliterans organizing pneumonia (BOOP), can sometimes mimic recurrent infectious pneumonitis. If serologic testing (eg, antineutrophil cytoplasmic antibodies [ANCA]) is negative, flexible fiberoptic bronchoscopy and transbronchial biopsy can be valuable in establishing a diagnosis. (See  <a class="medical medical_review" href="/d/html/4681.html" rel="external">"Pulmonary manifestations of systemic lupus erythematosus in adults", section on 'Other disorders'</a> and  <a class="medical medical_review" href="/d/html/4332.html" rel="external">"Cryptogenic organizing pneumonia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A secondary immunodeficiency, including HIV infection, hemoglobinopathy, multiple myeloma, underlying autoimmune process such as systemic lupus erythematosus or rheumatoid arthritis, or chronic lymphocytic leukemia, can lead to recurrent pneumonia [<a href="#rid21">21-24</a>]. HIV testing, hemoglobin electrophoresis, screening for autoimmune disease, and serum and urine electrophoresis for multiple myeloma may be indicated. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Older adult patients who survive an initial episode of pneumonia appear to have an increased risk of recurrent pneumonia associated with advancing age and decreasing functional status but often modifiable risk factors, such as smoking, glucocorticoid use, etc can be identified [<a href="#rid25">25</a>].</p><p></p><p class="headingAnchor" id="H24"><span class="h3">Initial immunologic evaluation</span><span class="headingEndMark"> — </span>Primary immunodeficiency should be suspected in adults with recurrent infections of the lung in association with other infections, such as sinusitis, otitis media, or bronchitis [<a href="#rid26">26-29</a>]. Possible explanations include a defect in antibody production or function, such as common variable immunodeficiency or one of several other antibody defects, or a milder variant of chronic granulomatous disease. (See  <a class="medical medical_review" href="/d/html/3928.html" rel="external">"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults"</a> and  <a class="medical medical_review" href="/d/html/3914.html" rel="external">"Primary humoral immunodeficiencies: An overview"</a> and  <a class="medical medical_review" href="/d/html/3913.html" rel="external">"Primary disorders of phagocyte number and/or function: An overview"</a>.)</p><p>Serum levels of immunoglobulin G (IgG), immunoglobulin A (IgA), immunoglobulin M (IgM), and immunoglobulin E (IgE) are screening tests for antibody defects. A screening test for chronic granulomatous disease, such as the flow cytometric dihydrorhodamine (DHR) 123 oxidation test, is also reasonable and widely available, although an unrelated control sample donor is generally required. (See  <a class="medical medical_review" href="/d/html/3914.html" rel="external">"Primary humoral immunodeficiencies: An overview"</a> and  <a class="medical medical_review" href="/d/html/3925.html" rel="external">"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis", section on 'Diagnosis'</a>.)</p><p>Two of the most common forms of antibody defects in adults are associated with normal levels of total IgG, IgA, IgM, and IgE:</p><p class="bulletIndent1"><span class="glyph">●</span>IgG subclass deficiency – This is often studied at the same time as quantitative immunoglobulin levels to expedite clinical evaluation. Deficiencies in IgG2 and/or IgG4 are particularly associated with recurrent respiratory tract infection. (See  <a class="medical medical_review" href="/d/html/3906.html" rel="external">"IgG subclass deficiency"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Specific antibody deficiency (also called polysaccharide nonresponse) – This assessment requires quantitative evaluation of antipolysaccharide antibody levels against encapsulated pathogens (eg, a panel of <em>Streptococcus pneumoniae</em> serotypes) and if low, the response following the administration of <a class="drug drug_general" data-topicid="9784" href="/d/drug information/9784.html" rel="external">pneumococcal polysaccharide vaccine</a>. (See  <a class="medical medical_review" href="/d/html/3965.html" rel="external">"Specific antibody deficiency"</a>.)</p><p></p><p>Interpretation of immunoglobulin levels and further testing for antibody defects are reviewed separately. (See  <a class="medical medical_review" href="/d/html/3903.html" rel="external">"Laboratory evaluation of the immune system", section on 'Antibody deficiency and defects'</a>.)</p><p class="headingAnchor" id="H25"><span class="h2">Urinary tract infections</span><span class="headingEndMark"> — </span>Isolated recurrent urinary tract infections, in the absence of infections in other organ systems, are not a typical presentation of immunodeficiency. Instead, local anatomic abnormalities are a more likely underlying cause. However, recurrent urinary tract infections are also a common problem in sexually active women without any identifiable predisposing condition.</p><p class="bulletIndent1"><span class="glyph">●</span>Anatomic abnormalities resulting in obstruction, stasis, reflux of urinary flow, and functional abnormalities, such as overactive bladder and incontinence [<a href="#rid30">30</a>], all predispose toward recurrent urinary infections. Although vesicoureteral reflux is monitored closely in children with recurrent urinary tract infection, some adults may have unrecognized reflux which might contribute to recurrent infection [<a href="#rid31">31</a>]. (See  <a class="medical medical_review" href="/d/html/8055.html" rel="external">"Bacterial adherence and other virulence factors for urinary tract infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent urinary tract infections are a common problem in sexually active women in the absence of an identifiable structural abnormality. Sexual activity may cause local irritation of the urethral meatus and lead to cystitis ("honeymoon cystitis"). Women with frequent recurrences often benefit from prevention strategies, including antibiotic prophylaxis that is given after intercourse. Menopausal women experience changes in the uroepithelium and local microbiome and may benefit from vaginal estrogen therapy if not otherwise contraindicated. (See  <a class="medical medical_review" href="/d/html/8053.html" rel="external">"Recurrent simple cystitis in women", section on 'Initial approach to prevention'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Older men can develop recurrent urinary tract infections with increasing frequency, largely due to obstructive and/or neurogenic abnormalities. Neurogenic abnormalities leading to hypotonic bladder result in urine stasis and an increased risk of infection. In about one-half of men with recurrent urinary tract infections, the prostate is the source of infection. (See  <a class="medical medical_review" href="/d/html/8062.html" rel="external">"Acute bacterial prostatitis", section on 'Risk factors'</a> and  <a class="medical medical_review" href="/d/html/86802.html" rel="external">"Chronic bacterial prostatitis", section on 'Antimicrobial penetration into prostatic tissue'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intraluminal (indwelling bladder catheter, calculi, neoplasms), intramural (ureteral stenosis, urethral strictures, prostatic obstruction), and extramural lesions (paravesical inflammatory mass, neoplasm, or fibrosis) all may predispose to recurrent urinary infection. (See  <a class="medical medical_review" href="/d/html/8054.html" rel="external">"Catheter-associated urinary tract infection in adults"</a>.)</p><p></p><p class="headingAnchor" id="H198241702"><span class="h2">Gastrointestinal infections</span></p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent focal infections, such as cholangitis, are due to local anatomic considerations, such as biliary tract obstruction (calculi, strictures, extrinsic compression by neoplasm or lymphadenopathy) or reflux (postoperative Roux-en-Y anastomosis). Recurrent diverticulitis is common among individuals with severe diverticular disease. Patients experiencing these focal infections are generally immunologically normal and do not require investigation for immunodeficiency. Recurrent bacterial peritonitis is associated with chronic ascites and/or peritoneal dialysis catheter placement. Among cirrhotic patients, the risk of recurrent bacterial peritonitis is roughly proportional to the severity of cirrhosis and portal hypertension [<a href="#rid32">32</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Relapsing and/or recurrent <em>Clostridioides </em>(formerly <em>Clostridium</em>) <em>difficile</em> colitis is increasingly common among immunologically normal individuals, attributable to the increasing use of broad-spectrum antibiotics (particularly in patients receiving multiple courses of antibiotic therapy for recurrent extraintestinal infections) and the enhanced virulence of circulating epidemic strains of NAP1 <em>C. difficile</em>. It is rarely a presentation of immunodeficiency. (See  <a class="medical medical_review" href="/d/html/2696.html" rel="external">"<i>Clostridioides difficile </i>infection in adults: Epidemiology, microbiology, and pathophysiology", section on 'PCR ribotype 027 strain'</a> and  <a class="medical medical_review" href="/d/html/2698.html" rel="external">"<i>Clostridioides difficile</i> infection in adults: Treatment and prevention"</a>.)</p><p></p><p class="bulletIndent1">Immunocompromised patients appear to be at increased risk for <em>C. difficile</em> colitis [<a href="#rid33">33</a>]. Underlying disorders, such as HIV, malignancy, or neutropenia are usually known at the time of <em>C. difficile</em> diagnosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Relapsing, recurrent, and/or progressive enterocolitis due to common enteropathogens, such as <em>Giardia</em>, enteroviruses, cytomegalovirus, and campylobacter, are associated with underlying hypogammaglobulinemia and/or T cell immunodeficiency. In addition, refractory bouts of enterocolitis due to unusual pathogens, such as <em>Microsporidia</em>, <em>Cyclospora</em>, or <em>Isospora</em>, should also raise the possibility of underlying immunodeficiency. (See  <a class="medical medical_review" href="/d/html/99315.html" rel="external">"Gastrointestinal manifestations in primary immunodeficiency"</a>.) </p><p></p><p class="headingAnchor" id="H198241722"><span class="h3">Initial immunologic evaluation</span><span class="headingEndMark"> — </span>It is reasonable to consider immunologic investigation for underlying neutropenia and T cell immunodeficiency in patients who experience severe primary <em>C. difficile</em> disease requiring hospitalization or refractory disease despite appropriate therapy when a clinical explanation is lacking. Granulocyte and lymphocyte assessment by complete blood count and differential white blood cell count, screening immunoglobulin levels (IgG, IgA, IgM), and T and B cell subset quantitation by flow cytometry are appropriate in patients with unusually severe gastrointestinal disease without apparent clinical explanation.</p><p class="headingAnchor" id="H26"><span class="h2">Meningitis</span><span class="headingEndMark"> — </span>Recurrences can occur with bacterial, viral, and noninfectious causes of meningitis.</p><p class="headingAnchor" id="H29"><span class="h3">Bacterial meningitis</span><span class="headingEndMark"> — </span>The epidemiology of recurrent bacterial meningitis was evaluated in a review of 493 episodes in 445 adults seen at a single center in Boston from 1962 to 1988 [<a href="#rid34">34</a>]. Among 275 patients with community-acquired meningitis, 17 (6.2 percent) had more than one episode of community-acquired disease, and 10 had three or more episodes.</p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent bacterial meningitis can result from a breach in the cranial vault. Defects in the cribriform plate, sphenoid or other sinuses, or temporal bone, or the presence of a craniopharyngeal canal may be congenital or acquired (post-traumatic or post-neurosurgical, especially in the setting of cerebrospinal fluid [CSF] rhinorrhea or other CSF leak). Recurrent meningitis also occurs with the use of indwelling medical devices (eg, Ommaya reservoirs, ventricular shunts, and cochlear implants) placed into the central nervous system. (See  <a class="medical medical_review" href="/d/html/1286.html" rel="external">"Infections of cerebrospinal fluid shunts"</a>.)</p><p></p><p class="bulletIndent1">A bony cranial defect can usually be detected by high-resolution computed tomography (HRCT) scanning [<a href="#rid35">35</a>]. Lumbar puncture and instillation of <a class="drug drug_general" data-topicid="8461" href="/d/drug information/8461.html" rel="external">fluorescein</a> or radionuclides for localizing a CSF leak are rarely necessary.</p><p></p><p class="bulletIndent1">Abnormalities in both complement and opsonizing antibodies have also been associated with recurrent bacterial meningitis:</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Deficiency of one or more of the terminal complement components (C5, C6, C7, C8, C9) has been associated with recurrent <em>Neisseria meningitidis</em> meningitis. Low complement levels may be due to either congenital complement deficiency or acquired diseases, such as systemic lupus erythematosus. (See  <a class="medical medical_review" href="/d/html/3962.html" rel="external">"Inherited disorders of the complement system"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immunoglobulin deficiency disorders or impaired reticuloendothelial function resulting from splenectomy or hemoglobinopathy are associated with an increased risk of bacteremia and meningitis due to encapsulated pathogens. Recurrent enteroviral (aseptic) meningitis has been associated with agammaglobulinemia [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/d/html/3914.html" rel="external">"Primary humoral immunodeficiencies: An overview"</a> and  <a class="medical medical_review" href="/d/html/1404.html" rel="external">"Clinical features, evaluation, and management of fever in patients with impaired splenic function"</a>.)</p><p></p><p class="headingAnchor" id="H973497028"><span class="h3">Mollaret's meningitis</span><span class="headingEndMark"> — </span>Mollaret's meningitis is a form of benign, recurrent aseptic (ie, nonbacterial) meningitis that is almost always due to herpes simplex type 2 (HSV-2) infection [<a href="#rid37">37</a>], although genital lesions are usually absent at the time of presentation. Aseptic meningitis has also been observed in patients with occult craniopharyngiomas [<a href="#rid38">38</a>], where episodic discharge of squamous debris triggers recurrent symptoms and inflammation of the CSF. In cases where HSV-2 does not appear to be the cause of illness based on negative cultures, the absence of viral material on polymerase chain reaction (PCR), and/or negative serology, CSF examination for birefringent material and cranial imaging may be quite helpful, as discussed separately. (See  <a class="medical medical_review" href="/d/html/8347.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection", section on 'Extragenital complications'</a> and  <a class="medical medical_review" href="/d/html/1296.html" rel="external">"Aseptic meningitis in adults"</a>.)</p><p class="headingAnchor" id="H973497074"><span class="h3">Noninfectious meningitis</span><span class="headingEndMark"> — </span>Noninfectious causes of meningitis that can recur include Behçet syndrome, chemical meningitis, neoplastic meningitis, Vogt-Koyanagi-Harada syndrome, and the hypersensitivity meningitis syndromes occasionally triggered by certain medications (eg, sulfonamides, <a class="drug drug_general" data-topicid="9026" href="/d/drug information/9026.html" rel="external">azathioprine</a>, nonsteroidal anti-inflammatory drugs [NSAIDs], and intravenous <a class="drug drug_general" data-topicid="16471" href="/d/drug information/16471.html" rel="external">immune globulin</a>) [<a href="#rid39">39</a>]. Recurrent episodes of noninfectious meningitis can occur in patients with systemic lupus erythematosus, even in the absence of drug triggers. (See  <a class="medical medical_review" href="/d/html/1296.html" rel="external">"Aseptic meningitis in adults"</a>.)</p><p class="headingAnchor" id="H30"><span class="h3">Initial immunologic evaluation</span><span class="headingEndMark"> — </span>In patients with recurrent meningitis and in those recovering from an initial episode of meningococcal meningitis, screening complement testing with C3, C4, and CH50 should be performed. A complete deficiency of any one of the terminal components (C5 through C9) gives an undetectable CH50 value, with the exception of C9 deficiency, which gives a low but detectable CH50 titer. If these initial tests are abnormal, further individual testing of the terminal complement components (C5 through C9) is warranted. In addition, levels of IgG, IgA, and IgM should be measured. In patients with recurrent pneumococcal meningitis, assessment of pneumococcal antibody titers, and review of S. pneumoniae serotypes as well as vaccine history (PPV23, <a class="drug drug_general" data-topicid="9906" href="/d/drug information/9906.html" rel="external">PCV13</a>) are important. </p><p class="headingAnchor" id="H31"><span class="h2">Brain abscess</span><span class="headingEndMark"> — </span>Anatomic factors are almost always responsible for the development of parenchymal brain abscesses. Although most brain abscesses result from direct extension from adjacent foci of infection, such as sinusitis or mastoiditis, a variety of remote abnormalities may be important in selected patients.</p><p>As an example, shunting of venous blood to the systemic circulation may occur through intracardiac right-to-left or bidirectional shunts, anomalous pulmonary arteries, shunting in patients with bronchiectasis, or extracardiac vascular malformations (eg, Rendu-Osler-Weber syndrome). In addition, extracranial infections that can seed the systemic arterial supply, such as lung abscesses and rarely subacute infective endocarditis, may predispose patients to the development of brain abscesses.</p><p class="headingAnchor" id="H973497346"><span class="h2">Oral and dental infections</span><span class="headingEndMark"> — </span>Adults with diabetes mellitus have an increased risk of periodontitis. Necrotizing ulcerative periodontitis is an especially severe form of the periodontitis that is seen in patients with a variety of underlying immunodeficiency states, most commonly HIV infection, as well as in patients undergoing chemotherapy for malignancies [<a href="#rid40">40,41</a>]. Oral infections and severe herpes simplex gingivostomatitis can also be seen in primary immunodeficiencies, as well as disorders of tooth development, and inflammatory oral lesions (<a class="graphic graphic_figure graphicRef111417" href="/d/graphic/111417.html" rel="external">figure 1</a>).</p><p class="headingAnchor" id="H32"><span class="h2">Bacteremia and sepsis</span><span class="headingEndMark"> — </span>Deficiency of C3 is associated with bacteremia due to encapsulated pathogens, such as <em>S. pneumoniae</em> and <em>Haemophilus influenzae</em>, as well as by enteropathogens, such as the <em>Salmonella</em> species. Recurrent bacteremia due to <em>S. aureus</em> and other gram positive pathogens, gram negative bacilli, as well as Candida species, often reflect reinfection due to indwelling central venous catheters or continued high risk behaviors such as intravenous drug use. Recurrent Candidemia has also been associated with underlying gastrointestinal disease [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/d/html/3962.html" rel="external">"Inherited disorders of the complement system", section on 'C3 deficiency'</a>.)</p><p class="headingAnchor" id="H8541561"><span class="h1">IMMUNODEFICIENCY IN ADULTS</span></p><p class="headingAnchor" id="H8541352"><span class="h2">Secondary immunodeficiency</span><span class="headingEndMark"> — </span>Secondary immune disorders are far more prevalent than primary immunodeficiencies and should be considered in the presence of underlying disease states, medications, or previous surgical procedures (<a class="graphic graphic_table graphicRef71244" href="/d/graphic/71244.html" rel="external">table 2</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Diabetes mellitus</p><p class="bulletIndent1"><span class="glyph">●</span>Human immunodeficiency virus (HIV) infection</p><p class="bulletIndent1"><span class="glyph">●</span>Cirrhosis</p><p class="bulletIndent1"><span class="glyph">●</span>Nephrotic syndrome</p><p class="bulletIndent1"><span class="glyph">●</span>Other protein-losing states, such as enteropathies, severe exudative skin disease including burn injury, and peritoneal dialysis</p><p class="bulletIndent1"><span class="glyph">●</span>Malnutrition</p><p class="bulletIndent1"><span class="glyph">●</span>Hemoglobinopathy</p><p class="bulletIndent1"><span class="glyph">●</span>Inflammatory bowel disease or rheumatoid arthritis receiving immunosuppressive therapies (particularly tumor necrosis factor [TNF] inhibitors)</p><p class="bulletIndent1"><span class="glyph">●</span>Neurologic disease</p><p class="bulletIndent1"><span class="glyph">●</span>Autoimmune disease</p><p class="bulletIndent1"><span class="glyph">●</span>Splenectomy</p><p class="bulletIndent1"><span class="glyph">●</span>Malignancy</p><p class="bulletIndent1"><span class="glyph">●</span>Radiation therapy</p><p class="bulletIndent1"><span class="glyph">●</span>Immunosuppressive agents, such as glucocorticoids and others</p><p class="bulletIndent1"><span class="glyph">●</span>Immunomodulatory agents, such as <a class="drug drug_general" data-topicid="9616" href="/d/drug information/9616.html" rel="external">rituximab</a>, <a class="drug drug_general" data-topicid="8925" href="/d/drug information/8925.html" rel="external">etanercept</a>, and others</p><p></p><p>The immunologic adverse effects of biologic therapies are reviewed elsewhere. (See  <a class="medical medical_review" href="/d/html/3939.html" rel="external">"Secondary immunodeficiency induced by biologic therapies"</a>.)</p><p class="headingAnchor" id="H8541589"><span class="h2">Primary immunodeficiency</span><span class="headingEndMark"> — </span>Primary immunodeficiencies, also called inborn errors of immunity, are not as rare as previously thought. A study published in 2007 estimated the prevalence of well-defined primary immunodeficiency disorders at 1 in approximately 1200 people in the United States, which is 10-fold higher than earlier estimates [<a href="#rid43">43</a>]. Hundreds of specific disorders have been identified [<a href="#rid44">44</a>]. Some of these disorders, particularly some antibody defects, are of mild or moderate clinical severity (eg, specific antibody deficiency, immunoglobulin G [IgG] subclass deficiencies, selective immunoglobulin A [IgA] deficiency) and routinely escape detection until adulthood [<a href="#rid45">45,46</a>]. </p><p class="headingAnchor" id="H8541628"><span class="h3">What is an excessive number of infections?</span><span class="headingEndMark"> — </span>The number of infections experienced by an otherwise healthy adult can vary tremendously from year to year, depending on multiple factors, such as exposure to children, variations in the incidence and virulence of common respiratory viruses, stress levels, and other transient fluctuations in health status.</p><p>"Warning signs" of primary immunodeficiency in adults have been developed to help patients and clinicians recognize excessive infections [<a href="#rid47">47,48</a>]. Primary immunodeficiency should be considered when an adult has experienced <strong>any one</strong> of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Four or more infections requiring antibiotics within one year (eg, sinusitis, bronchitis, pneumonia, otitis media, especially with perforation).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recurring infections or infection requiring or not responding to prolonged antibiotic therapy and requiring intravenous antibiotic therapy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Two or more severe bacterial infections (osteomyelitis or septic arthritis, meningitis, septicemia, cellulitis).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Two or more radiologically proven pneumonias within three years (particularly if severe enough to require hospitalization and/or intravenous antibiotics or associated with slow recovery, intrathoracic spread of infection, or necrotizing pneumonia).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infection with unusual localization or unusual pathogen.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent deep abscesses of the skin, lymph nodes, or internal organs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic diarrhea with weight loss, especially due to campylobacter or cryptosporidiosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Persistent thrush especially in the absence of recently administered antibiotics.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent, prolonged, and unexplained fevers.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A family history of primary immunodeficiency.</p><p></p><p>In addition to these warning signs, several other health problems are more common in patients with immunodeficiency, such as poor wound healing (may be seen with neutropenia) and unexplained bronchiectasis [<a href="#rid49">49</a>]. (See  <a class="medical medical_review" href="/d/html/15080.html" rel="external">"Basic principles of wound healing"</a> and  <a class="medical medical_review" href="/d/html/1444.html" rel="external">"Clinical manifestations and diagnosis of bronchiectasis in adults", section on 'Etiologies'</a>.)</p><p>Patients who have two or more warning signs or other history to suggest an immune problem should still be evaluated for secondary immune disorders and anatomic causes of recurrent infections because the latter categories of illness are more common than primary immunodeficiency. If neither of these problems is identified, then an evaluation for primary immunodeficiency is appropriate.</p><p class="headingAnchor" id="H8541635"><span class="h3">Noninfectious manifestations of immunodeficiency</span><span class="headingEndMark"> — </span>In addition to infections, many immune disorders are associated with autoimmune disease and a higher risk of malignancies. A fundamental function of the immune system is to distinguish "self" from "nonself." This capacity is critical not only for defense against invading micro-organisms but also for the prevention of autoimmune disease and detection and destruction of malignant cells. Some immunodeficiencies are also associated with higher rates of allergic disease, which is another manifestation of immune dysregulation.</p><p>Autoimmune disorders that are seen in patients with immunodeficiencies include autoimmune thyroiditis, autoimmune hemolytic anemia, thrombocytopenia, or neutropenia, pernicious anemia, celiac disease, and vitiligo [<a href="#rid49">49</a>]. Inflammatory diseases, such as arthritis, inflammatory bowel disease, pyoderma gangrenosum [<a href="#rid50">50</a>], and connective tissue disorders are also seen with increased frequency. (See  <a class="medical medical_review" href="/d/html/16362.html" rel="external">"Autoimmunity in patients with inborn errors of immunity/primary immunodeficiency"</a>.)</p><p>Malignancies that are most common in patients with immunodeficiencies are non-Hodgkin lymphoma and Hodgkin lymphoma. (See  <a class="medical medical_review" href="/d/html/95906.html" rel="external">"Malignancy in inborn errors of immunity", section on 'Epidemiology and prevalence of cancer in IEI'</a>.)</p><p>Thus, the clinician's threshold for initiating an evaluation of the immune system should be lower in a patient with disorders in one or more of these categories of disease.</p><p class="headingAnchor" id="H8541379"><span class="h1">PATTERNS OF INFECTION</span><span class="headingEndMark"> — </span>Patients with immunodeficiency typically experience stereotypic patterns of recurrent infection, which provide clues regarding which portion of the immune system is affected. The laboratory evaluation of each of these components of the immune system is reviewed separately. (See  <a class="medical medical_review" href="/d/html/3903.html" rel="external">"Laboratory evaluation of the immune system"</a>.)</p><p class="headingAnchor" id="H8541386"><span class="h2">Defects in immunoglobulins and/or complement proteins</span><span class="headingEndMark"> — </span>Recurrent sinopulmonary infections, chronic gastrointestinal infections, bacteremia, and/or meningitis are associated with defects in immunoglobulins and/or complement proteins. Common pathogens include the encapsulated bacteria, <em>S. pneumoniae</em>, <em>H. influenzae</em> type b, and <em>N. meningitidis</em>, as well as <em>Giardia</em>, <em>Cryptosporidia</em>, and <em>Campylobacter</em>. (See  <a class="medical medical_review" href="/d/html/3914.html" rel="external">"Primary humoral immunodeficiencies: An overview"</a> and  <a class="medical medical_review" href="/d/html/3962.html" rel="external">"Inherited disorders of the complement system"</a>.)</p><p class="headingAnchor" id="H8541393"><span class="h2">Granulocyte (neutrophil) defects</span><span class="headingEndMark"> — </span>Recurrent invasive skin and soft tissue infections, especially focal abscesses requiring incision and drainage, are associated with granulocyte (neutrophil) defects. Characteristic organisms are catalase-positive organisms, such as S<em>. aureus</em>, gram-negative bacilli, <em>Aspergillus</em>, and <em>Nocardia</em>. (See  <a class="medical medical_review" href="/d/html/3913.html" rel="external">"Primary disorders of phagocyte number and/or function: An overview"</a>.)</p><p class="headingAnchor" id="H8541400"><span class="h2">Defects in cell-mediated immunity</span><span class="headingEndMark"> — </span>Progressive infections with ordinarily "benign" viruses, opportunistic intracellular pathogens, or fungi suggest defective cell-mediated immunity, particularly defects of T cells. Typical micro-organisms include cytomegalovirus, Epstein-Barr virus or other herpes viruses, mycobacteria (both M. tuberculosis and nontuberculous mycobacteria), and fungi (<em>Candida</em>, <em>Cryptococcus</em>, and <em>Pneumocystis</em>). Natural killer (NK) cell defects also present with severe and fulminant herpes virus infections, although these conditions are rare. (See  <a class="medical medical_review" href="/d/html/3955.html" rel="external">"Severe combined immunodeficiency (SCID): An overview"</a> and  <a class="medical medical_review" href="/d/html/3935.html" rel="external">"Combined immunodeficiencies: An overview"</a> and  <a class="medical medical_review" href="/d/html/3949.html" rel="external">"NK cell deficiency syndromes: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H8541407"><span class="h2">Other disorders</span><span class="headingEndMark"> — </span>Some disorders cause recurrent infections that do not fit into one of these simple patterns. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>Leukocyte-adhesion deficiency (LAD) results in both lymphocyte and phagocyte dysfunction. As a result, both bacterial infections and life-threatening viral infections may recur early in life. Patients with milder phenotypes of LAD-I can survive into adulthood. (See  <a class="medical medical_review" href="/d/html/3918.html" rel="external">"Leukocyte-adhesion deficiency"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hyperimmunoglobulin E syndrome (Job syndrome), classically a multisystem disorder resulting from defects in intracellular signaling pathways, should be suspected in adults with infected eczema, pneumatoceles, mucocutaneous candidiasis, recurrent cutaneous and respiratory tract bacterial infections, and marked elevation of serum immunoglobulin E (IgE). (See  <a class="medical medical_review" href="/d/html/3960.html" rel="external">"Autosomal dominant hyperimmunoglobulin E syndrome"</a>.)</p><p></p><p class="headingAnchor" id="H4362894"><span class="h1">REFERRAL</span><span class="headingEndMark"> — </span>Referral to a variety of specialists may be needed, depending upon the expertise and interest of the generalist, as well as the availability of specialists.</p><p class="bulletIndent1"><span class="glyph">●</span>For patients with recurrent infections that may be due to an underlying anatomic abnormality or may not actually be infectious in nature, such as sinusitis or urinary tract infection, referral to a specialist in that organ system may be most helpful (eg, otolaryngologist, urologist/urogynecologist).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Referral to an infectious diseases specialist is appropriate for patients with underlying disorders, such as human immunodeficiency virus (HIV) infection, or for those in whom there may be an issue of chronic bacterial colonization or carriage (recurrent pharyngitis). The infectious diseases clinician usually has the most experience in formulating antibiotic strategies for acute therapy and prophylaxis that may minimize morbidity.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For suspected primary or secondary immunodeficiency, an allergist/immunologist is likely to be most helpful, and referral should be considered before advanced immunologic testing is undertaken [<a href="#rid51">51</a>]. Tests of immune function are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/3903.html" rel="external">"Laboratory evaluation of the immune system"</a>.)</p><p></p><p class="headingAnchor" id="H33"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Usual causes of recurrent infections</strong> – The vast majority of adults presenting with recurrent infections, especially localized to one organ system, have an anatomic abnormality or underlying condition that predisposes to infections of that type, rather than an immune defect (<a class="graphic graphic_table graphicRef87023" href="/d/graphic/87023.html" rel="external">table 1</a>). Common examples include allergic rhinitis causing recurrent sinusitis, uncontrolled asthma predisposing to pneumonia, or saphenous venectomy causing recurrent cellulitis. (See <a class="local">'Overview of etiologies'</a> above and <a class="local">'Considerations by site of infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Secondary versus primary immunodeficiency states</strong> – When an immune defect is suspected in an adult, secondary causes of immunodeficiency (eg, diabetes, immune-altering medications) are more common than primary immunodeficiencies (<a class="graphic graphic_table graphicRef71244" href="/d/graphic/71244.html" rel="external">table 2</a>). (See <a class="local">'Overview of etiologies'</a> above and <a class="local">'Immunodeficiency in adults'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clues to primary immunodeficiencies in adults</strong> – Primary immunodeficiency occasionally presents for the first time in adulthood. Affected patients may also have autoimmune disease and/or a history of malignancy (especially lymphomas), as these disorders are also manifestations of abnormal immune function. A history of one or more of these types of disorders in a patient with recurrent infections should raise suspicion of an underlying immunodeficiency. (See <a class="local">'Noninfectious manifestations of immunodeficiency'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Referral </strong>– Referral to a variety of different specialists may be needed, depending upon the expertise and interest of the generalist, as well as the availability of specialists. Referral to an allergist/immunologist or infectious disease specialist is best pursued before extensive immunologic testing is initiated. (See <a class="local">'Referral'</a> above.)</p><p></p><p class="headingAnchor" id="H99695439"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate acknowledge E Richard Stiehm, MD, who contributed as a Section Editor to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Wheeler JG. Evaluating the child with recurrent infections. Am Fam Physician 1996; 54:2276.</a></li><li><a class="nounderline abstract_t">Holland SM, Gallin JI. Evaluation of the patient with recurrent bacterial infections. Annu Rev Med 1998; 49:185.</a></li><li><a class="nounderline abstract_t">Arbiser JL. Genetic immunodeficiencies: cutaneous manifestations and recent progress. J Am Acad Dermatol 1995; 33:82.</a></li><li><a class="nounderline abstract_t">Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiencies. N Engl J Med 1995; 333:431.</a></li><li><a class="nounderline abstract_t">Ong PY, Leung DY. Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review. Clin Rev Allergy Immunol 2016; 51:329.</a></li><li><a class="nounderline abstract_t">Sreeramoju P, Porbandarwalla NS, Arango J, et al. Recurrent skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus requiring operative debridement. Am J Surg 2011; 201:216.</a></li><li><a class="nounderline abstract_t">Karppelin M, Siljander T, Vuopio-Varkila J, et al. Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study. Clin Microbiol Infect 2010; 16:729.</a></li><li><a class="nounderline abstract_t">Johnston SL. Clinical immunology review series: an approach to the patient with recurrent superficial abscesses. Clin Exp Immunol 2008; 152:397.</a></li><li><a class="nounderline abstract_t">Haller PR. Infections in intravenous drug abusers. What makes them different. Postgrad Med 1988; 83:95.</a></li><li><a class="nounderline abstract_t">Selinger DS, Chongsiriwatana K, Froelich CJ, et al. Telltale mouth flora: a clue to the diagnosis of factitious recurrent thigh abscesses. South Med J 1979; 72:225.</a></li><li><a class="nounderline abstract_t">Yawn BP, Wollan PC, Kurland MJ, et al. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc 2011; 86:88.</a></li><li><a class="nounderline abstract_t">Brook I, Gober AE. Failure to eradicate streptococci and beta-lactamase producing bacteria. Acta Paediatr 2008; 97:193.</a></li><li><a class="nounderline abstract_t">Wayne KS, Taussig LM. Probable familial congenital bronchiectasis due to cartilage deficiency (Williams-Campbell syndrome). Am Rev Respir Dis 1976; 114:15.</a></li><li><a class="nounderline abstract_t">Marini T, Hobbs SK, Chaturvedi A, Kaproth-Joslin K. Beyond bronchitis: a review of the congenital and acquired abnormalities of the bronchus. Insights Imaging 2017; 8:141.</a></li><li><a class="nounderline abstract_t">Gay S, Dee P. Tracheobronchomegaly--the Mounier-Kuhn syndrome. Br J Radiol 1984; 57:640.</a></li><li><a class="nounderline abstract_t">Gordeuk V, Keeports R, Rexrode W. Cystic fibrosis in adults. N Engl J Med 1978; 299:1137.</a></li><li><a class="nounderline abstract_t">di Sant'agnese PA, Davis PB. Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature. Am J Med 1979; 66:121.</a></li><li><a class="nounderline abstract_t">Gan KH, Veeze HJ, van den Ouweland AM, et al. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med 1995; 333:95.</a></li><li><a class="nounderline abstract_t">Knowles MR, Barnett TB, McConkie-Rosell A, et al. Mild cystic fibrosis in a consanguineous family. Ann Intern Med 1989; 110:599.</a></li><li><a class="nounderline abstract_t">Eliasson R, Mossberg B, Camner P, Afzelius BA. The immotile-cilia syndrome. A congenital ciliary abnormality as an etiologic factor in chronic airway infections and male sterility. N Engl J Med 1977; 297:1.</a></li><li><a class="nounderline abstract_t">Kirkpatrick MB, Haynes J Jr, Bass JB Jr. Results of bronchoscopically obtained lower airway cultures from adult sickle cell disease patients with the acute chest syndrome. Am J Med 1991; 90:206.</a></li><li><a class="nounderline abstract_t">Weeks JC, Tierney MR, Weinstein MC. Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. N Engl J Med 1991; 325:81.</a></li><li><a class="nounderline abstract_t">Subesinghe S, Rutherford AI, Byng-Maddick R, et al. Recurrent serious infections in patients with rheumatoid arthritis-results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 2018; 57:651.</a></li><li><a class="nounderline abstract_t">Singh BK, Singh S. Systemic lupus erythematosus and infections. Reumatismo 2020; 72:154.</a></li><li><a class="nounderline abstract_t">Dang TT, Majumdar SR, Marrie TJ, Eurich DT. Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients. Drugs Aging 2015; 32:13.</a></li><li><a class="nounderline abstract_t">Rodríguez-Créixems M, Muñoz P, Miranda E, et al. Recurrent pneumococcal bacteremia. A warning of immunodeficiency. Arch Intern Med 1996; 156:1429.</a></li><li><a class="nounderline abstract_t">Ambrosino DM, Siber GR, Chilmonczyk BA, et al. An immunodeficiency characterized by impaired antibody responses to polysaccharides. N Engl J Med 1987; 316:790.</a></li><li><a class="nounderline abstract_t">Umetsu DT, Ambrosino DM, Quinti I, et al. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 1985; 313:1247.</a></li><li><a class="nounderline abstract_t">Moss RB, Carmack MA, Esrig S. Deficiency of IgG4 in children: association of isolated IgG4 deficiency with recurrent respiratory tract infection. J Pediatr 1992; 120:16.</a></li><li><a class="nounderline abstract_t">Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA 2014; 311:844.</a></li><li><a class="nounderline abstract_t">Salib A, Rudnick B, Murphy A. Vesicoureteral Reflux in Adults with Urinary Tract Infections: Is There a Role for Treatment? Curr Urol Rep 2020; 21:35.</a></li><li><a class="nounderline abstract_t">Termsinsuk P, Auesomwang C. Factors that predict recurrent spontaneous bacterial peritonitis in cirrhotic patients. Int J Clin Pract 2020; 74:e13457.</a></li><li><a class="nounderline abstract_t">McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018; 66:e1.</a></li><li><a class="nounderline abstract_t">Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328:21.</a></li><li><a class="nounderline abstract_t">Mantur M, Łukaszewicz-Zając M, Mroczko B, et al. Cerebrospinal fluid leakage--reliable diagnostic methods. Clin Chim Acta 2011; 412:837.</a></li><li><a class="nounderline abstract_t">Mease PJ, Ochs HD, Wedgwood RJ. Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia. N Engl J Med 1981; 304:1278.</a></li><li><a class="nounderline abstract_t">Shalabi M, Whitley RJ. Recurrent benign lymphocytic meningitis. Clin Infect Dis 2006; 43:1194.</a></li><li><a class="nounderline abstract_t">Maeda T, Kazumi T, Hotta K, et al. Aseptic localized peritonitis in a patient with chemical meningitis associated with craniopharyngioma cysts. Intern Med 1993; 32:340.</a></li><li><a class="nounderline abstract_t">Rosenberg J, Galen BT. Recurrent Meningitis. Curr Pain Headache Rep 2017; 21:33.</a></li><li><a class="nounderline abstract_t">Dalla Torre D, Burtscher D, Jank S, Kloss FR. Necrotizing periodontitis as a possible manifestation of common variable immunodeficiency. Int J Oral Maxillofac Surg 2012; 41:1546.</a></li><li><a class="nounderline abstract_t">Oveisi M, Barzilay O, Hanafi AA. Periodontal disease in immunodeficient patients: Clinical guidelines for diagnosis and management. Int Dent J Student Res 2015; 3:96.</a></li><li><a class="nounderline abstract_t">Ala-Houhala M, Anttila VJ. Characteristics of late recurrent candidemia in adult patients. Mycoses 2021; 64:503.</a></li><li><a class="nounderline abstract_t">Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol 2007; 27:497.</a></li><li><a class="nounderline abstract_t">Tangye SG, Al-Herz W, Bousfiha A, et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 2022; 42:1473.</a></li><li><a class="nounderline abstract_t">García JM, Gamboa P, de la Calle A, et al. Diagnosis and management of immunodeficiencies in adults by allergologists. J Investig Allergol Clin Immunol 2010; 20:185.</a></li><li><a class="nounderline abstract_t">Nelson KS, Lewis DB. Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves. Curr Opin Infect Dis 2010; 23:359.</a></li><li class="breakAll">The 6 warning signs for primary immunodeficiency in adults were developed by the European Society for Immunodeficiencies. Available on the web at http://www.esid.org/workingparty.php?party=3&amp;sub=2id=175.</li><li class="breakAll">Ten warning signs for primary immunodeficiency in adults. http://www.info4pi.org/aboutPI/index.cfm?section=aboutPI&amp;content=warningsignsadult&amp;CFID=40450642&amp;CFTOKEN=62808651 (Accessed on November 06, 2012).</li><li><a class="nounderline abstract_t">Azar AE, Ballas ZK. Evaluation of the adult with suspected immunodeficiency. Am J Med 2007; 120:764.</a></li><li><a class="nounderline abstract_t">Marzano AV, Borghi A, Meroni PL, Cugno M. Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol 2016; 175:882.</a></li><li><a class="nounderline abstract_t">Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol 2015; 136:1186.</a></li></ol></div><div id="topicVersionRevision">Topic 3908 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8940960" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Evaluating the child with recurrent infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9509258" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Evaluation of the patient with recurrent bacterial infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7601952" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Genetic immunodeficiencies: cutaneous manifestations and recent progress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7616993" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The primary immunodeficiencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27377298" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20832054" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Recurrent skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus requiring operative debridement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19694769" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18422735" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Clinical immunology review series: an approach to the patient with recurrent superficial abscesses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3353349" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Infections in intravenous drug abusers. What makes them different.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/424800" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Telltale mouth flora: a clue to the diagnosis of factitious recurrent thigh abscesses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21220354" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Herpes zoster recurrences more frequent than previously reported.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18254908" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Failure to eradicate streptococci and beta-lactamase producing bacteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/937831" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Probable familial congenital bronchiectasis due to cartilage deficiency (Williams-Campbell syndrome).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27966195" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Beyond bronchitis: a review of the congenital and acquired abnormalities of the bronchus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6733410" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Tracheobronchomegaly--the Mounier-Kuhn syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/703799" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Cystic fibrosis in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/420238" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7539891" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : A cystic fibrosis mutation associated with mild lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2930093" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Mild cystic fibrosis in a consanguineous family.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/301245" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The immotile-cilia syndrome. A congenital ciliary abnormality as an etiologic factor in chronic airway infections and male sterility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1996589" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Results of bronchoscopically obtained lower airway cultures from adult sickle cell disease patients with the acute chest syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1904989" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29340619" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Recurrent serious infections in patients with rheumatoid arthritis-results from the British Society for Rheumatology Biologics Register.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33213128" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Systemic lupus erythematosus and infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25491559" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8678711" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Recurrent pneumococcal bacteremia. A warning of immunodeficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3493431" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : An immunodeficiency characterized by impaired antibody responses to polysaccharides.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3877240" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1731015" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Deficiency of IgG4 in children: association of isolated IgG4 deficiency with recurrent respiratory tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24570248" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Urinary tract infections in older women: a clinical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32785798" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Vesicoureteral Reflux in Adults with Urinary Tract Infections: Is There a Role for Treatment?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31799716" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Factors that predict recurrent spontaneous bacterial peritonitis in cirrhotic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29462280" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8416268" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Acute bacterial meningitis in adults. A review of 493 episodes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21334321" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Cerebrospinal fluid leakage--reliable diagnostic methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6783908" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17029141" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Recurrent benign lymphocytic meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8358128" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Aseptic localized peritonitis in a patient with chemical meningitis associated with craniopharyngioma cysts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28551737" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Recurrent Meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23062717" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Necrotizing periodontitis as a possible manifestation of common variable immunodeficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Periodontal disease in immunodeficient patients: Clinical guidelines for diagnosis and management</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33377571" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Characteristics of late recurrent candidemia in adult patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17577648" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Population prevalence of diagnosed primary immunodeficiency diseases in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35748970" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20635783" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Diagnosis and management of immunodeficiencies in adults by allergologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20581672" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20581672" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20581672" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17765042" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Evaluation of the adult with suspected immunodeficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27106250" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26371839" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Practice parameter for the diagnosis and management of primary immunodeficiency.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
